GEN and GNMSF Related Headlines

Go Back

GEN and GNMSF Related Press Releases

Go Back

Aug 13, 2014 11:10AM Genmab Announces Financial Results for the First Half of 2014 and Improves 2014 Financial Guidance
Aug 11, 2014 09:23AM Genmab Announces New Phase III Study of Daratumumab in Front Line Multiple Myeloma
Jul 31, 2014 02:50PM GSK and Genmab Announce Positive Interim Result for Phase III Study of Ofatumumab as Maintenance Therapy for Relapsed CLL
Jul 23, 2014 07:11AM Second Quarter 2014 Net Sales Figures for Arzerra(r)
Jul 18, 2014 09:18AM Genmab Announces Phase III Study of Daratumumab in Front Line Multiple Myeloma
Jul 14, 2014 09:59AM Genmab to Receive Milestone Payment in DuoBody Platform Collaboration with Janssen
Jul 7, 2014 10:23AM Genmab Reaches USD 25 Million Milestone in Daratumumab Collaboration with Janssen
Jul 3, 2014 09:38AM GSK and Genmab Receive EU Authorization for Arzerra(tm) (ofatumumab) as First-Line Treatment for Chronic Lymphocytic Leukemia (CLL) in Combination with Chlorambucil or Bendamustine for Patients Inelig
Jun 27, 2014 02:27PM GSK and Genmab announce top-line results from a Phase III study of ofatumumab versus physicians' choice for bulky fludarabine-refractory CLL
Jun 4, 2014 02:27AM Genmab Announces DuoBody and HexaBody Platform Collaboration With Undisclosed Biotechnology Company
May 30, 2014 11:04AM Genmab Announces Ofatumumab Development Plans in RRMS and NMO

GEN and GNMSF Related SEC Filings

Go Back